NEW YORK (GenomeWeb) – DNAnexus said today that it has closed a $68 million Series F round of venture funding. Existing investors GV — formerly Google Ventures — Foresite Capital, TPG Biotech, WuXi NextCode, and Claremont Creek Ventures participated, while Innovatus Capital Partners provided both debt and equity financing.